Yüklüyor......
Safety of targeting ROR1 in primates with chimeric antigen receptor-modified T cells
Genetic engineering of T cells for adoptive transfer by introducing a tumor-targeting chimeric antigen receptor (CAR) is a new approach to cancer immunotherapy. A challenge for the field is to define cell surface molecules that are both preferentially expressed on tumor cells and can be safely targe...
Kaydedildi:
| Yayımlandı: | Cancer Immunol Res |
|---|---|
| Asıl Yazarlar: | , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4324006/ https://ncbi.nlm.nih.gov/pubmed/25355068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-14-0163 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|